Key Insights

Highlights

Treatment Research

2 treatments under study, led by Endoscopic Followup

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT03222635Not ApplicableRecruiting

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma

NCT04818476Unknown

Outcomes of Endoscopically Resected High-risk Mucosal and Low- and High-risk Submucosal Adenocarcinoma Arising in Barrett's Esophagus

Showing all 2 trials

Research Network

Common Treatments

  • Endoscopic Followup1
  • Diagnostic Endoscopic Resection1

Active Sponsors

  • Amsterdam UMC1
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1

Top Investigators

Related Conditions

  • Barrett Esophagus2
  • Submucosal Esophageal Adenocarcinoma2
  • Adenocarcinoma Esophagus1

Activity Timeline